Cleveland Cavaliers owner Dan Gilbert turns grief over son’s rare disease into search for a cure
Dan Gilbert, owner of the Cleveland Cavaliers, has turned his grief over the loss of his son Nick into a mission to find a cure for neurofibromatosis. Despite battling the disease for years, Nick remained determined and engaged with his community until his passing in 2023. Gilbert reflects on the challenges of wealth and access to medical care when faced with such a devastating illness.
- ▪Nick Gilbert battled neurofibromatosis, undergoing multiple surgeries and treatments.
- ▪He was a beloved figure in both Detroit and Cleveland, known for his determination and spirit.
- ▪Dan Gilbert expressed frustration at the limitations of medical advancements despite his resources.
CNBC — Top files mainly under finance. We currently carry 510 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | US Top News and Analysis |
| Canonical URL | https://www.cnbc.com/2026/05/21/cavs-owner-dan-gilbert-son-rare-disease-cure.html |
| Publication time | Thu, 21 May 2026 14:45:55 GMT |
| Retrieval time | 2026-05-21T11:56:11.031Z |
| Last seen | 2026-05-21T14:52:58.527Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | RSirGOg-MzXj |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
After the surgery, Nick underwent several rounds of chemo and radiation therapy. But he didn't let that stand in the way of achieving his goals. Despite his battle with NF, Nick was still able to maintain close friendships, attend Michigan State, and even work as an intern in the business development unit at his dad's company. But by 2018, the disease was catching up with him."There were some tumors, that just kind of got away from us," Gilbert said. "We had two major surgeries that year. And from that point on, until 2023 when we lost him, there were just surgeries and chemo."Gilbert says they tried everything, but a tumor on his brainstem grew too quickly for them to manage. "These weren't cancerous tumors.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at US Top News and Analysis.
Discussion
0 commentsMore from US Top News and Analysis
